Skip to main content
Clinical Trials/NCT04393623
NCT04393623
Completed
Not Applicable

Understanding and Targeting Stress Reactivity in Women Veterans With Alcohol Misuse

VA Office of Research and Development1 site in 1 country81 target enrollmentNovember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alcohol Use Disorder
Sponsor
VA Office of Research and Development
Enrollment
81
Locations
1
Primary Endpoint
Change in frequency of alcohol use prior to and through study completion
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of the study "Stress, Emotion Regulation, and Alcohol in Women Veterans" is to learn about the effects of negative emotion and stress on behavior (including alcohol use) among women Veterans, including women with and without posttraumatic stress disorder. Additionally, the study looks at whether a woman's use of emotion regulation techniques changes the association between stress or negative emotion and behavior. Lastly, the study examines how women's reactions to stress, and the effects of stress, vary across the menstrual cycle - depending on the level of circulating hormones.

Detailed Description

Aims for the current study are two-fold: 1. conduct a randomized trial testing the effects of an emotion regulation skill (cognitive reappraisal) on stress-induced drinking among women with alcohol misuse and varying levels of co-occurring PTSD; 2. examine whether progesterone levels and/or severity of co-occurring PTSD - factors which impact women's stress reactivity and emotion regulation - moderate the effectiveness of the cognitive reappraisal in reducing stress-induced drinking. The proposed study will combine experimental, in-person sessions with daily self-report data from the Veterans to assess the effect of cognitive reappraisal on alcohol craving, cognitive (inhibitory) control, physiological arousal (HRV), and alcohol use. Participation will take place across a period of at least 35 days, to encompass an entire menstrual cycle. All participants complete all sections of the study - the experimental sessions and the longitudinal (35-day) data collection.

Registry
clinicaltrials.gov
Start Date
November 1, 2020
End Date
September 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Current alcohol misuse, defined as scoring 3 or higher on the AUDIT-C
  • If using other illicit substances, alcohol is their primary substance of use
  • Alcohol use in the past 45 days
  • Able to write and speak in English
  • Served in the U.S. Military
  • Willing to provide blood samples at laboratory sessions to assay hormone levels and take urine ovulation tests at home

Exclusion Criteria

  • Psychotic symptoms or uncontrolled Bipolar Disorder (screened for during session 1 using SCID-5 screening modules)
  • Brain damage or were in an accident that affects ability to complete the computerized task
  • Current (past 3 months) active suicidal ideation or intent
  • Current pregnancy

Outcomes

Primary Outcomes

Change in frequency of alcohol use prior to and through study completion

Time Frame: Retrospectively for 45 days prior to study enrollment, and through study completion (up to 75 days post-baseline)

The Alcohol Timeline Follow Back (TLFB) assesses frequency/quantity of drinking. The TLFB will be used at all laboratory sessions to fill in any potentially missing data from the daily logs

Change in Alcohol Craving during Experimental Sessions

Time Frame: Two separate days during the study (ie. on two of the study days, which last up to 75 days)

Craving will be measured via the Alcohol Craving Questionnaire - Short Form (ACQ-SF). The ACQ-SF comprises 12 items and is used to assess alcohol cravings among alcohol users in the current moment. Participants are asked to rate how much they agree or disagree with each statement, each regarding how they feel or think about alcohol in the moment. Each item is scored on a 7-point Likert scale that reflects their agreement on a scale of "strongly disagree" to "strongly agree".

Change in Inhibitory Control during Experimental Sessions

Time Frame: Two separate days during the study (ie. on two of the study days, which last up to 75 days)

Inhibitory Control, a measure of behavioral impulsivity, will be assessed with a computerized task (a stop-signal task, STOP-IT). Participants' stop signal reaction time (SSRT) reflects varying levels of inhibitory control (lower SSRT reflects better inhibitory control).

Change in Heart Rate Variability (HRV) during Experimental Sessions

Time Frame: Two separate days during the study (ie. on two of the study days, which last up to 75 days)

Heart rate variability (HRV), a physiological measure of arousal and shown to be a measure of stress reactivity and impacted by successful emotion regulation, will be assessed with a Biopac MP160 data acquisition unit with an ECG amplifier that allows for the measurement of HRV.

Secondary Outcomes

  • Change in intensity of daily negative affect(Daily, through study completion (up to 75 days post-baseline))
  • Change in depression symptoms from baseline to study completion, un to 75 days(Baseline, end of study (up to 75 days))
  • Change in use of adaptive and maladaptive emotion regulation strategies(weekly, through study completion (up to 75 days post-baseline))

Study Sites (1)

Loading locations...

Similar Trials